Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added and revision v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    A new revision (v3.4.2) was added to the study record history; the previous revision (v3.4.1) was removed along with its associated notice.
    Difference
    0.8%
    Check dated 2026-02-11T09:19:45.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A government funding status notice was added and the page revision label updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-04T05:33:50.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Glossary is now shown and the page uses green and red highlights to indicate additions and deletions, with the revision updated to v3.4.0 (No FEAR Act Data reflected in the UI). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T03:47:30.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision history shows an added Revision: v3.3.4 and removal of Revision: v3.3.3, reflecting an internal update to the site’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:16:18.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A new Revision: v3.3.3 entry appeared and the references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. These are minor maintenance updates that do not affect study details or user-facing content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:40:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.